MTOR and cardiac hypertrophy: In fact, reduced mTOR activity through rapamycin supplementation alleviated age-dependent cardiac hypertrophy and diastolic dysfunction in mice as well as reduced dysregulated mitochondria and ROS generation (Dai et al., 2014).